PortfoliosLab logo

Aerie Pharmaceuticals, Inc. (AERI)

Equity · Currency in USD · Last updated Mar 28, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in Aerie Pharmaceuticals, Inc. in Jun 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $14,373 for a total return of roughly 43.73%. All prices are adjusted for splits and dividends.

-4.00%-2.00%0.00%2.00%4.00%6.00%8.00%Oct 02Oct 09Oct 16Oct 23Oct 30Nov 06Nov 13
AERI (Aerie Pharmaceuticals, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with AERI

Aerie Pharmaceuticals, Inc.


Aerie Pharmaceuticals, Inc. had a return of 117.24% year-to-date (YTD) and 40.04% in the last 12 months. Over the past 10 years, Aerie Pharmaceuticals, Inc. had an annualized return of 4.09%, while the S&P 500 had an annualized return of 9.38%, indicating that Aerie Pharmaceuticals, Inc. did not perform as well as the benchmark.

1 month0.46%6.60%
6 months113.59%1.65%
1 year40.04%-15.43%
5 years (annualized)-23.65%8.99%
10 years (annualized)4.09%9.38%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aerie Pharmaceuticals, Inc. Sharpe ratio is 0.56. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.

-1.00-0.500.000.50Oct 02Oct 09Oct 16Oct 23Oct 30Nov 06Nov 13
AERI (Aerie Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Dividend History

Aerie Pharmaceuticals, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%Oct 02Oct 09Oct 16Oct 23Oct 30Nov 06Nov 13
AERI (Aerie Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Aerie Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aerie Pharmaceuticals, Inc. is 93.30%, recorded on Jun 1, 2022. The portfolio has not recovered from it yet.



To Bottom


To Recover



-93.3%Jul 20, 2018974Jun 1, 2022
-73.52%Apr 24, 20156May 1, 2015350Sep 20, 2016356
-44.78%Mar 5, 201446May 8, 201433Jun 25, 201479
-39.55%Jun 27, 201429Aug 7, 201477Nov 25, 2014106
-26.56%Jan 16, 20148Jan 28, 201421Feb 27, 201429
-26.5%Oct 23, 2017138May 10, 201819Jun 7, 2018157
-23.32%Mar 8, 201750May 17, 20176May 25, 201756
-21.5%Jan 5, 201523Feb 5, 201530Mar 20, 201553
-19.82%Oct 11, 201619Nov 4, 20167Nov 15, 201626
-19.13%Sep 19, 20179Sep 29, 20178Oct 11, 201717

Volatility Chart

Current Aerie Pharmaceuticals, Inc. volatility is 0.90%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

0.00%10.00%20.00%30.00%40.00%Oct 02Oct 09Oct 16Oct 23Oct 30Nov 06Nov 13
AERI (Aerie Pharmaceuticals, Inc.)
Benchmark (^GSPC)